AzTrials
AzTrials

Tobacco Use DisorderNCT03764969

Modification of Goal-directed and Habitual Behavior in Addiction

A study testing standard smoking cessation program (SCP), Cognitive remediation treatment (CRT) and Implicit computer-based habit-modifying training (ICHT) in people with Tobacco Use Disorder, run by Central Institute of Mental Health, Mannheim at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the modification of the hypothesized imbalance between goal-directed and habitual behavior and its neural correlates in smokers. Two interventions will be used as add-on trainings to a smoking cessation program. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Tobacco Use Disorder
What is being tested?
standard smoking cessation program (SCP), Cognitive remediation treatment (CRT) and Implicit computer-based habit-modifying training (ICHT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteGermany
Study dates
7 Jan 2020to 23 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • severe tobacco use disorder (TUD) according to DSM-5
  • sufficient ability to communicate with investigators and answer questions in both written and verbal format
  • ability to provide fully informed consent and to use self-rating scales

Who cannot join

  • severe internal, neurological, and/or psychiatric comorbidities; other Axis I mental disorders other than TUD according to ICD-10 and DSM 5 (except for mild depression, i.e. F32.0, adjustment disorder and specific phobias) in the last 12 months
  • history of brain injury
  • severe physical diseases
  • common exclusion criteria for MRI (e.g. metal, claustrophobia)
  • positive drug screening (opioids, benzodiazepines, barbiturates, cocaine, amphetamines)
  • psychotropic medication within the last 14 days
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit

    Mannheim, Baden-Wurttemberg, 68159

Other trials in Germany

About this study

Official title: Modification of the Imbalance Between Goal-directed and Habitual Behavior in Human Addiction

This study aims to examine the modification of the hypothesized imbalance between goal-directed and habitual behavior and its neural correlates in smokers. Two interventions will be used as add-on trainings to a smoking cessation program.

Read the detailed description

In this study, the investigators aim to assess the imbalance between goal-directed and habitual behavior, its neural basis and how it can be differentially modified in treatment-seeking smokers, using two training interventions. The first intervention is cognitive remediation treatment (CRT), also known as cognitive enhancement therapy, focusing on improving inhibitory control and executive functions. The second intervention, a computer-based habit-modifying training focusing on implicit drug seeking ("implicit computer-based habit-modifying training", ICHT) uses a conditioning approach through implicit priming and contextual modulation. Indicators of the imbalance will be examined with respect to reward devaluation, cue reactivity and a pavlovian instrumental transfer (PIT) paradigm. The investigators hypothesize that both interventions change the balance between goal-directed and habitual behavior but by different mechanisms. Whereas CRT should directly increase cognitive control, in contrast, ICHT should affect the early processing and the emotional valence of smoking and smoking cues.

Being tested
standard smoking cessation program (SCP), Cognitive remediation treatment (CRT), Implicit computer-based habit-modifying training (ICHT)
Keywords
Addiction, Nicotine, Smoking Cessation, Relapse, Craving, habitual behavior, cognitive remediation, implicit priming, pavlovian instrumental transfer
Medical subject headings
Tobacco Use Disorder, Behavior, Addictive, Smoking Cessation, Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standard smoking cessation program (SCP)Behavioural

    Each subject will receive standard SCP as group treatment once a week (1 hour) over six weeks. This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra \& Buchkremer 2004), and will be carried out by a qualified therapist.

  • Cognitive remediation treatment (CRT)Behavioural

    Cognitive remediation treatment (CRT) employing a chess-based battery of tasks two times per week over six weeks as a group treatment in our outpatient clinic (60 min duration per session).

  • Implicit computer-based habit-modifying training (ICHT)Behavioural

    Implicit computer-based habit-modifying training (ICHT), applied twice a week for six weeks. In this training, the participants perform a two-part training. First, a subliminal presentation (20 ms) of negative valenced primes before smoking-cues in context and secondly, a subliminal presentation of positive valenced primes before potentially reinforcing events.

Study groups in NCT03764969
Study groupRoleWhat they receive
standard smoking cessation program (SCP)Active comparatorstandard smoking cessation program
Receives: Behavioral: standard smoking cessation program (SCP)
SCP + CRTExperimentalSCP plus cognitive remediation treatment (CRT)
Receives: Behavioral: standard smoking cessation program (SCP); Behavioral: Cognitive remediation treatment (CRT)
SCP + ICHTExperimentalSCP plus an implicit computer-based habit-modifying training (ICHT)
Receives: Behavioral: standard smoking cessation program (SCP); Behavioral: Implicit computer-based habit-modifying training (ICHT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in imbalance between goal-directed and habitual behavior

    measured by reward devaluation procedure (Hogarth \& Chase 2011)

    Measured: 2 time points: before and after 6 weeks SCP

  2. Change in implicit smoking-related associations

    smoking-related implicit association task (Wiers et al. 2016).

    Measured: 3 time points: before and after 6 weeks SCP plus after 3 months

  3. Change in attentional bias to smoking cues

    smoking-related dot-probe task (Vollstädt-Klein et al. 2009).

    Measured: 3 time points: before and after 6 weeks SCP plus after 3 months

  4. Change in smoking urges

    questionnaire of smoking urges (QSU, Müller et al. 2001)); self-report questionnaire; two subscales: "intention and desire to smoke / anticipation of pleasure from smoking" (range 11 - 77) and "anticipation of relief from negative affect and nicotine withdrawal / urgent and overwhelming desire to smoke" (range 10 - 70) high values represent high craving

    Measured: 3 time points: before and after 6 weeks SCP plus after 3 months

  5. Change in working memory capacity

    Spatial Working Memory task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994)

    Measured: 3 time points: before and after 6 weeks SCP plus after 3 months

  6. Change in planning ability

    One Touch Stockings of Cambridge task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994)

    Measured: 3 time points: before and after 6 weeks SCP plus after 3 months

  7. Change in cognitive flexibility

    Internal-External Set Shifting task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994)

    Measured: 3 time points: before and after 6 weeks SCP plus after 3 months

Secondary outcomes (3)
  1. nicotine consumption

    self-report

    Measured: 3 months follow-up

  2. Change in neural PIT effect

    PIT phase of a choice task (adapted from Hogarth \& Chase 2011)

    Measured: 2 time points: before and after 6 weeks SCP

  3. Change in neural cue reactivity

    fMRI cue-reactivity task (Vollstädt-Klein et al. 2011)

    Measured: 2 time points: before and after 6 weeks SCP

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2018
  2. Study start7 Jan 2020
  3. Primary completion23 Jun 2023
  4. Study completion23 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03764969
Sponsor's protocol ID
TRR265 C01
Status last verified
Oct 2023
First submitted
28 Nov 2018
Last updated
5 Oct 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Karl D, Wieland A, Shevchenko Y, Grundinger N, Machunze N, Gerhardt S, Flor H, Vollstadt-Klein S. Using computer-based habit versus chess-based cognitive remediation training as add-on therapy to modify the imbalance between habitual behavior and cognitive control in tobacco use disorder: protocol of a randomized controlled, fMRI study. BMC Psychol. 2023 Jan 25;11(1):24. doi: 10.1186/s40359-023-01055-z.

    PubMed 36698210

Questions about this trial

What is this clinical trial studying?

A study testing standard smoking cessation program (SCP), Cognitive remediation treatment (CRT) and Implicit computer-based habit-modifying training (ICHT) in people with Tobacco Use Disorder, run by Central Institute of Mental Health, Mannheim at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in imbalance between goal-directed and habitual behavior (time frame: 2 time points: before and after 6 weeks SCP). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03764969, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in